CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn
用户wxb8loTerxGI
1小时前
5
10
求助中
帖子自动结束时间: 2026-05-19 09:24:05
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
S Wymann, RAV Morales, WH Toh…
International Journal of …, 2026
mdpi.com
… IgG-based complement inhibitor would be expected to be accelerated by the co-administered FcRn … Having demonstrated CSL305 acting as a complement inhibitor and FcRn …

